文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

芳香族代谢产物参与脓毒性休克发病机制

Involvement of Aromatic Metabolites in the Pathogenesis of Septic Shock.
PubMed 文献 · Shock · 2018-01-01
一句话结论社区获得性肺炎患者中,脓毒性休克者苯乳酸、对羟基苯乙酸、对羟基苯乳酸水平显著高于非休克者,且与休克、乳酸、HVA、NT-proBNP相关。

研究假设苯乳酸(PhLA)、对羟基苯乙酸(p-HPhAA)、对羟基苯乳酸(p-HPhLA)等芳香族微生物代谢产物(AMM)参与脓毒性休克发病。纳入社区获得性肺炎患者,入住ICU时及次日采集临床和实验室数据,按是否发生脓毒性休克分组比较AMM、儿茶酚胺代谢产物、乳酸、NT-proBNP、iNOS和PCT。结果休克组入院时PhLA、p-HPhAA、p-HPhLA、HVA、乳酸显著更高,iNOS显著更低;次日两组PCT和NT-proBNP也有显著差异。∑3AMM与休克、乳酸、HVA、NT-proBNP相关,作者认为可能与AMM降低酪氨酸羟化酶活性、限制儿茶酚胺合成有关。

要点

  • 脓毒性休克组入院时PhLA为2.3 μmol/L,非休克组为0.8 μmol/L。
  • 脓毒性休克组入院时p-HPhAA为4.6 μmol/L,非休克组为1.4 μmol/L。
  • 脓毒性休克组入院时p-HPhLA为7.4 μmol/L,非休克组为2.6 μmol/L。
  • ∑3AMM与入院时乳酸、HVA、NT-proBNP的相关系数分别为0.67、0.57、0.38,次日分别为0.73、0.76、0.6(P < 0.01)。
  • 作者认为AMM可能通过降低酪氨酸羟化酶活性、限制儿茶酚胺合成参与脓毒性休克发病。

适用人群与场景

  • 社区获得性肺炎患者,入住ICU时及次日采集临床和实验室数据。
  • 按是否发生脓毒性休克分为脓毒性休克组(20例)和非脓毒性休克组(21例)。

研究设计与关键结果

  • 研究比较社区获得性肺炎患者中脓毒性休克组(20例)与非脓毒性休克组(21例)的临床和实验室数据。
  • 入院时脓毒性休克组PhLA为2.3 μmol/L vs. 非休克组0.8 μmol/L,p-HPhAA为4.6 μmol/L vs. 1.4 μmol/L,p-HPhLA为7.4 μmol/L vs. 2.6 μmol/L,脓毒性休克组均显著更高。
  • 入院时脓毒性休克组HVA和乳酸显著更高,iNOS显著更低。
  • 次日两组PCT和NT-proBNP水平也有显著差异。
  • ∑3AMM与入院时休克、乳酸、HVA、NT-proBNP的相关系数分别为0.44、0.67、0.57、0.38,次日分别为0.59、0.73、0.76、0.6(P < 0.01)。

证据类型、等级与局限

  • 证据类型:临床观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为AMM参与脓毒性休克的发病机制,其机制可能为AMM降低酪氨酸羟化酶活性,从而限制儿茶酚胺的合成。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: We hypothesized that aromatic microbial metabolites (AMM), such as phenyllactic (PhLA), p-hydroxyphenylacetic (p-HPhAA), and p-hydroxyphenyllactic (p-HPhLA) acids, contribute to the pathogenesis of septic shock.

METHODS: Clinical and laboratory data of patients with community-acquired pneumonia were obtained on intensive care unit admission and the next day. Patients were divided into two groups based on septic shock presence or absence. The levels of AMM (PhLA, p-HPhAA, p-HPhLA, and their sum, ∑3AMM), catecholamine metabolites (3,4-dihydroxymandelic [DHMA], 3,4-dihydroxyphenylacetic [DOPAC], and homovanillic [HVA] acids), lactate, N-terminal pro-brain natriuretic peptide (NT-proBNP), inducible nitric oxide synthase (iNOS), and procalcitonin (PCT) were compared. Correlations between AMM and clinical and laboratory data were calculated.

RESULTS: There were 20 patients in the septic shock group and 21 in the nonseptic shock group. On admission, the septic shock patients demonstrated significantly higher levels of PhLA (2.3 vs. 0.8 μmol/L), p-HPhAA (4.6 vs. 1.4 μmol/L), p-HPhLA (7.4 vs. 2.6 μmol/L), HVA, lactate, and significantly lower levels of iNOS. The next day, the two groups also showed significant differences in the levels of PCT and NT-proBNP. The correlation between ∑3AMM and presence of shock, levels of lactate, HVA, and NT-proBNP on admission was 0.44, 0.67, 0.57, and 0.38, respectively, and the correlation on the next day was 0.59, 0.73, 0.76, and 0.6, respectively (P < 0.01). These findings can be explained by the ability of AMM to reduce tyrosine hydroxylase activity, thus limiting the synthesis of catecholamines.

CONCLUSIONS: AMM are involved in the pathogenesis of septic shock.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Beloborodova NV, Sarshor YN, Bedova AY, et al. Involvement of Aromatic Metabolites in the Pathogenesis of Septic Shock. Shock. 2018. PMID: 29189605. doi:10.1097/SHK.0000000000001064

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。